In healthy individuals, FMO3 rapidly converts TMA to odorless TMAO
Cotadutide (MEDI0382) is the most extensively developed dual GLP-1/glucagon receptor agonist, showing significant improvements in glucose control, BW (likely mediated by reduced energy intake rather than increased energy expenditure), hepatic fat, and albuminuria in a small RCT on patients with T2D and overweight or obesity 45,46
doi:10.1007/s00592-025-02525 71
Ces derniers lutilisent majoritairement pour les bnfices quon lui prte en matire de perte de poids, de performance et de rcupration
This natural hormone plays a vital role in regulating appetite and glucose metabolism
With obesity, no one wants to accept medication as a chronic treatment